GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Thursday, 18th Apr 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0650 $0.110
52 weeks $0.0600 $1.31

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
2024-03-13 $0.0748 $0.0748 $0.0748 $0.0748 0
2024-03-12 $0.0748 $0.0748 $0.0748 $0.0748 0
2024-03-11 $0.0748 $0.0748 $0.0748 $0.0748 0
2024-03-08 $0.0748 $0.0748 $0.0748 $0.0748 0
2024-03-07 $0.0748 $0.0748 $0.0748 $0.0748 0
2024-03-06 $0.0748 $0.0748 $0.0748 $0.0748 0
2024-03-05 $0.0748 $0.0748 $0.0748 $0.0748 0
2024-03-04 $0.0801 $0.0900 $0.0717 $0.0748 6 059
2024-03-01 $0.0801 $0.0899 $0.0801 $0.0801 3 271
2024-02-29 $0.0801 $0.0801 $0.0801 $0.0801 172
2024-02-28 $0.0757 $0.0870 $0.0757 $0.0801 1 998
2024-02-27 $0.0997 $0.0997 $0.0830 $0.0914 4 905
2024-02-26 $0.0745 $0.0899 $0.0745 $0.0810 12 823
2024-02-23 $0.0940 $0.0940 $0.0701 $0.0745 235 412
2024-02-22 $0.0732 $0.0996 $0.0732 $0.0881 2 558
2024-02-21 $0.0820 $0.0900 $0.0820 $0.0820 1 728
2024-02-20 $0.0820 $0.0920 $0.0820 $0.0820 3 232
2024-02-16 $0.0820 $0.102 $0.0820 $0.0860 11 531
2024-02-15 $0.104 $0.104 $0.0820 $0.0820 2 376
2024-02-14 $0.0900 $0.100 $0.0850 $0.0991 58 368
2024-02-13 $0.0900 $0.0999 $0.0900 $0.0900 2 217
2024-02-12 $0.0900 $0.0999 $0.0900 $0.0959 31 440
2024-02-09 $0.0900 $0.0959 $0.0900 $0.0900 2 572
2024-02-08 $0.0820 $0.0994 $0.0820 $0.0900 16 988
2024-02-07 $0.0815 $0.110 $0.0815 $0.0820 4 958
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT